All

Results: 15769-15780 of 82853

PR Newswire associated0

FAST III trial demonstrates non-inferiority of CAAS vFFR to invasive wire-based FFR

PR Newswire associated0

Landmark ALL-RISE® Trial Results Presented at ACC.26: CathWorks FFRangio Demonstrates Similar Clinical Outcomes to Invasive Wire-based Physiology Assessment

EVENING CHRONOTYPE - OR 'NIGHT OWL' PATTERN - AT HIGHER RISK OF BIPOLAR-LINKED MOOD PATTERNS

EVENING CHRONOTYPE - OR 'NIGHT OWL' PATTERN - AT HIGHER RISK OF BIPOLAR-LINKED MOOD PATTERNS

Presswire associated0

Teenagers who struggle to understand their emotions more at risk of social media addiction

Presswire associated0

GENETIC PREDISPOSITION TO ADHD LINKED TO ECONOMIC CHALLENGES ACROSS THE LIFE COURSE

Business Wire logo

Takeda’s Zasocitinib Delivered Rapid and Durable Skin Clearance in a Convenient Once-Daily Pill, Affirming Promise to Reshape Psoriasis Care

Business Wire logo

Incyte Announces New Positive 54-Week Late-Breaking Data for Povorcitinib in Hidradenitis Suppurativa at the 2026 American Academy of Dermatology (AAD) Annual Meeting

PR Newswire associated0

Can Digital Technologies Safeguard Cultural Diversity? 40 Global Cases Offer the Answer

PR Newswire associated0

Zoomex Launches Earning Initiative as Inflation Drives Shift Toward Capital Efficiency in Crypto Markets

PR Newswire associated0

Zoomex to Attend EthCC Cannes, Focusing on Industry Dialogue and Infrastructure Development

Business Wire logo

AAD 2026: Late-Breaking Nemolizumab Data Demonstrate Clinically Meaningful Benefits for Children Aged 2 to 11 With Moderate-to-Severe Atopic Dermatitis